Alliance Pharma Share Price | |
---|---|
Price | 39.70 |
Bid | 39.50 |
Ask | 39.70 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 39.70 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £214.54m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 233.52941 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.259% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Mar-24 | 17:53:05 | 39.70 | 1,980 | Unknown* | 39.50 | 39.70 | 786.06 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:52:53 | 39.70 | 28 | Unknown* | 39.50 | 39.70 | 11.12 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:45:25 | 39.483 | 3,960 | Unknown* | 39.50 | 39.70 | 1,564 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:44:37 | 38.696 | 3,209 | Unknown* | 39.50 | 39.70 | 1,242 | O Ordinary Was reported as OTC |
28-Mar-24 | 16:40:53 | 39.63 | 212,918 | Unknown* | 39.50 | 39.70 | 84.38k | O Ordinary Delayed publication |
28-Mar-24 | 17:09:54 | 39.611 | 30,377 | Unknown* | 39.50 | 39.70 | 12.03k | O Ordinary Was reported as OTC |
28-Mar-24 | 17:03:49 | 39.70 | 5,279 | Unknown* | 39.50 | 39.70 | 2,096 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:03:26 | 39.70 | 4,180 | Unknown* | 39.50 | 39.70 | 1,659 | O Ordinary Was reported as OTC |
28-Mar-24 | 16:35:23 | 39.70 | 66,726 | Buy* | 39.50 | 39.70 | 26.49k | UT Uncrossing Trade |
28-Mar-24 | 16:21:40 | 39.70 | 5,757 | Buy* | 39.65 | 39.70 | 2,286 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions